{"id":"https://openalex.org/W7166314847","doi":"https://doi.org/10.1007/s13555-026-01833-8","title":"Abrocitinib Achieves Early and Complete/Near-Complete Skin Clearance Plus Itch-Free State in Atopic Dermatitis: Phase 3 Pooled Post Hoc Analysis","display_name":"Abrocitinib Achieves Early and Complete/Near-Complete Skin Clearance Plus Itch-Free State in Atopic Dermatitis: Phase 3 Pooled Post Hoc Analysis","publication_year":2026,"publication_date":"2026-06-27","ids":{"openalex":"https://openalex.org/W7166314847","doi":"https://doi.org/10.1007/s13555-026-01833-8","pmid":"https://pubmed.ncbi.nlm.nih.gov/42365219"},"language":"en","primary_location":{"id":"doi:10.1007/s13555-026-01833-8","doi":"https://doi.org/10.1007/s13555-026-01833-8","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13555-026-01833-8","pdf_url":"https://link.springer.com/content/pdf/10.1007/s13555-026-01833-8.pdf","source":{"id":"https://openalex.org/S4210222097","display_name":"Dermatology and Therapy","issn_l":"2190-9172","issn":["2190-9172","2193-8210"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","ki-jl-1","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatology and Therapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://link.springer.com/content/pdf/10.1007/s13555-026-01833-8.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087084947","display_name":"Stephan Weidinger","orcid":"https://orcid.org/0000-0003-3944-252X","observed_orcids":["https://orcid.org/0000-0003-3944-252X"]},"institutions":[{"id":"https://openalex.org/I4210112713","display_name":"University Hospital Schleswig-Holstein","ror":"https://ror.org/01tvm6f46","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210112713"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Stephen Weidinger","raw_affiliation_strings":["Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany","institution_ids":["https://openalex.org/I4210112713"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000572878","display_name":"Kristian Reich","orcid":"https://orcid.org/0000-0001-5248-4332","observed_orcids":["https://orcid.org/0000-0001-5248-4332"]},"institutions":[{"id":"https://openalex.org/I4210108711","display_name":"University Medical Center Hamburg-Eppendorf","ror":"https://ror.org/01zgy1s35","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I159176309","https://openalex.org/I4210108711"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Kristian Reich","raw_affiliation_strings":["Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany","institution_ids":["https://openalex.org/I4210108711"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004467268","display_name":"Naiem Tony Issa","orcid":"https://orcid.org/0000-0002-5885-3909","observed_orcids":["https://orcid.org/0000-0002-5885-3909"]},"institutions":[{"id":"https://openalex.org/I145608581","display_name":"University of Miami","ror":"https://ror.org/02dgjyy92","country_code":"US","type":"education","lineage":["https://openalex.org/I145608581"]},{"id":"https://openalex.org/I193531525","display_name":"George Washington University","ror":"https://ror.org/00y4zzh67","country_code":"US","type":"education","lineage":["https://openalex.org/I193531525"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Naiem Issa","raw_affiliation_strings":["Dr. Philip Frost Department of Dermatology & Cutaneous Surgery, University of Miami Miller School of Medicine Miami, Miami, FL, USA","Forefront Dermatology, Vienna, VA, USA","Issa Research & Consulting, LLC, Springfield, VA, USA","The Department of Dermatology, The George Washington University School of Medicine & Health Sciences, Washington, DC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dr. Philip Frost Department of Dermatology & Cutaneous Surgery, University of Miami Miller School of Medicine Miami, Miami, FL, USA","institution_ids":["https://openalex.org/I145608581"]},{"raw_affiliation_string":"Forefront Dermatology, Vienna, VA, USA","institution_ids":[]},{"raw_affiliation_string":"Issa Research & Consulting, LLC, Springfield, VA, USA","institution_ids":[]},{"raw_affiliation_string":"The Department of Dermatology, The George Washington University School of Medicine & Health Sciences, Washington, DC, USA","institution_ids":["https://openalex.org/I193531525"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050332949","display_name":"Chih-ho Hong","orcid":"https://orcid.org/0000-0001-9963-8319","observed_orcids":["https://orcid.org/0000-0001-9963-8319"]},"institutions":[{"id":"https://openalex.org/I141945490","display_name":"University of British Columbia","ror":"https://ror.org/03rmrcq20","country_code":"CA","type":"education","lineage":["https://openalex.org/I141945490"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"H. Chih-ho Hong","raw_affiliation_strings":["Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada","institution_ids":["https://openalex.org/I141945490"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020785070","display_name":"Christopher G. Bunick","orcid":"https://orcid.org/0000-0002-4011-8308","observed_orcids":["https://orcid.org/0000-0002-4011-8308"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher G. Bunick","raw_affiliation_strings":["Department of Dermatology, Yale School of Medicine, New Haven, CT, USA","Program in Translational Biomedicine, Yale School of Medicine, New Haven, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Yale School of Medicine, New Haven, CT, USA","institution_ids":["https://openalex.org/I32971472"]},{"raw_affiliation_string":"Program in Translational Biomedicine, Yale School of Medicine, New Haven, CT, USA","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079043748","display_name":"Pinaki Biswas","orcid":"https://orcid.org/0009-0009-3494-4142","observed_orcids":["https://orcid.org/0009-0009-3494-4142"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pinaki Biswas","raw_affiliation_strings":["Pfizer Inc., New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc., New York, NY, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5126464872","display_name":"Gary Chan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gary Chan","raw_affiliation_strings":["Pfizer, Inc., Groton, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer, Inc., Groton, CT, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065130489","display_name":"Erman G\u00fcler","orcid":"https://orcid.org/0009-0006-1240-5269","observed_orcids":["https://orcid.org/0009-0006-1240-5269"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Erman G\u00fcler","raw_affiliation_strings":["Pfizer Inc., Istanbul, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc., Istanbul, Turkey","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014312724","display_name":"Melissa Watkins","orcid":"https://orcid.org/0009-0002-8547-6624","observed_orcids":["https://orcid.org/0009-0002-8547-6624"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melissa Watkins","raw_affiliation_strings":["Pfizer Inc., New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc., New York, NY, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045024401","display_name":"Justine Alderfer","orcid":"https://orcid.org/0000-0003-3006-1675","observed_orcids":["https://orcid.org/0000-0003-3006-1675"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Justine Alderfer","raw_affiliation_strings":["Pfizer Inc., 500 Arcola Rd, Collegeville, PA, 19426, USA. justine.alderfer@pfizer.com"],"raw_orcid":"https://orcid.org/0000-0003-3006-1675","affiliations":[{"raw_affiliation_string":"Pfizer Inc., 500 Arcola Rd, Collegeville, PA, 19426, USA. justine.alderfer@pfizer.com","institution_ids":["https://openalex.org/I180857899"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5045024401"],"corresponding_institution_ids":["https://openalex.org/I180857899"],"apc_list":{"value":7400,"currency":"USD","value_usd":7400},"apc_paid":{"value":7400,"currency":"USD","value_usd":7400},"fwci":6.3998,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.96108971,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":96},"biblio":{"volume":"16","issue":"8","first_page":"4217","last_page":"4225"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/abrocitinib","display_name":"abrocitinib","score":1.0},{"id":"https://openalex.org/keywords/atopic-dermatitis","display_name":"atopic dermatitis","score":0.996999979019165},{"id":"https://openalex.org/keywords/jak-inhibitors","display_name":"JAK inhibitors","score":0.9449999928474426},{"id":"https://openalex.org/keywords/eczema-area-and-severity-index","display_name":"Eczema Area and Severity Index","score":0.8970000147819519},{"id":"https://openalex.org/keywords/pruritus","display_name":"pruritus","score":0.9330000281333923},{"id":"https://openalex.org/keywords/skin-clearance","display_name":"skin clearance","score":0.8370000123977661},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.4259999990463257}],"concepts":[{"id":"https://openalex.org/C67761136","wikidata":"https://www.wikidata.org/wiki/Q2105849","display_name":"Post-hoc analysis","level":2,"score":0.7318999767303467},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5817999839782715},{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.47510001063346863},{"id":"https://openalex.org/C2992886853","wikidata":"https://www.wikidata.org/wiki/Q18381816","display_name":"Post hoc","level":2,"score":0.4627000093460083},{"id":"https://openalex.org/C48103436","wikidata":"https://www.wikidata.org/wiki/Q599031","display_name":"State (computer science)","level":2,"score":0.4032000005245209},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3190000057220459},{"id":"https://openalex.org/C138944611","wikidata":"https://www.wikidata.org/wiki/Q1163287","display_name":"Clearance","level":2,"score":0.29429998993873596},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.24940000474452972},{"id":"https://openalex.org/C2986587452","wikidata":"https://www.wikidata.org/wiki/Q938438","display_name":"Statistical analysis","level":2,"score":0.2273000031709671},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.2231999933719635}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1007/s13555-026-01833-8","doi":"https://doi.org/10.1007/s13555-026-01833-8","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13555-026-01833-8","pdf_url":"https://link.springer.com/content/pdf/10.1007/s13555-026-01833-8.pdf","source":{"id":"https://openalex.org/S4210222097","display_name":"Dermatology and Therapy","issn_l":"2190-9172","issn":["2190-9172","2193-8210"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","ki-jl-1","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatology and Therapy","raw_type":"journal-article"},{"id":"pmid:42365219","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42365219","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatology and therapy","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:c6229920f04947e48664ed2ca079c579","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/c6229920f04947e48664ed2ca079c579","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Dermatology and Therapy, Vol 16, Iss 8, Pp 4217-4225 (2026)","raw_type":"article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13493657","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13493657/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Dermatol Ther (Heidelb)","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1007/s13555-026-01833-8","doi":"https://doi.org/10.1007/s13555-026-01833-8","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13555-026-01833-8","pdf_url":"https://link.springer.com/content/pdf/10.1007/s13555-026-01833-8.pdf","source":{"id":"https://openalex.org/S4210222097","display_name":"Dermatology and Therapy","issn_l":"2190-9172","issn":["2190-9172","2193-8210"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","ki-jl-1","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatology and Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/2","display_name":"Zero hunger","score":0.47084903717041016}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7166314847.pdf","grobid_xml":"https://content.openalex.org/works/W7166314847.grobid-xml"},"referenced_works_count":14,"referenced_works":["https://openalex.org/W3136297743","https://openalex.org/W4211013257","https://openalex.org/W4224326447","https://openalex.org/W4286515998","https://openalex.org/W4292684063","https://openalex.org/W4381189146","https://openalex.org/W4388454963","https://openalex.org/W4389900297","https://openalex.org/W4399786031","https://openalex.org/W4399803590","https://openalex.org/W4400547319","https://openalex.org/W4403667407","https://openalex.org/W7131100123","https://openalex.org/W7158094314"],"related_works":[],"abstract_inverted_index":{"INTRODUCTION:":[0],"Abrocitinib,":[1],"a":[2],"Janus":[3],"kinase":[4],"inhibitor,":[5],"is":[6],"approved":[7],"for":[8],"patients":[9,91,117,147,195],"with":[10,96,119,128,130,135,139,170,196,201],"moderate-to-severe":[11,197],"atopic":[12,198],"dermatitis.":[13],"METHODS:":[14],"This":[15],"post":[16],"hoc":[17],"analysis":[18],"assessed":[19],"the":[20,34,44,65,81],"onset":[21],"and":[22,47,51,69,75,137,180],"depth":[23],"of":[24,26,37,57,90,116,146,152,204],"response":[25],"abrocitinib":[27,97,120,131,171],"100":[28,132,174],"or":[29,173],"200":[30,98,121,172],"mg":[31,99,122,175],"in":[32,43,64,80,109,176,194],"achieving":[33],"stringent":[35],"outcome":[36],"\u2265":[38],"90%":[39],"improvement":[40],"from":[41],"baseline":[42,153],"Eczema":[45],"Area":[46],"Severity":[48],"Index":[49],"score":[50,56],"Peak":[52],"Pruritus":[53],"Numerical":[54],"Rating":[55],"0":[58],"to":[59,161,165],"1":[60],"(EASI-90":[61],"+":[62,94,125,168],"PP-NRS0/1)":[63],"JADE":[66,70,82,110,113,177],"DARE":[67],"(NCT04345367)":[68],"COMPARE":[71],"(NCT03720470)":[72],"clinical":[73,85],"trials,":[74],"previous":[76],"dupilumab":[77,102,162,206],"inadequate":[78],"responders":[79],"EXTEND":[83,178],"(NCT03422822)":[84],"trial.":[86],"RESULTS:":[87],"Higher":[88],"proportions":[89,145],"achieved":[92,123,148],"EASI-90":[93,124,167],"PP-NRS0/1":[95,126,169],"(5.8%)":[100],"versus":[101],"(1.1%)":[103],"as":[104,106],"early":[105],"week":[107,142],"2":[108],"DARE.":[111],"In":[112],"COMPARE,":[114],"27.1%":[115],"treated":[118,200],"compared":[127],"20.2%":[129],"mg,":[133],"15.5%":[134],"dupilumab,":[136],"5.4%":[138],"placebo":[140],"at":[141],"16.":[143],"Similar":[144],"this":[149],"endpoint":[150],"irrespective":[151],"itch.":[154],"Patients":[155],"whose":[156],"disease":[157,189],"did":[158],"not":[159],"respond":[160],"were":[163],"able":[164],"achieve":[166],"(16.7%":[179],"18.5%,":[181],"respectively).":[182],"CONCLUSION:":[183],"These":[184],"findings":[185],"suggest":[186],"that":[187],"minimal":[188],"activity":[190],"can":[191],"be":[192],"attained":[193],"dermatitis":[199],"abrocitinib,":[202],"regardless":[203],"prior":[205],"exposure.":[207],"TRIAL":[208],"REGISTRATION:":[209],"Clinicaltrials.gov":[210],"identifiers:":[211],"NCT04345367":[212],"(JADE":[213,216,219],"DARE),":[214],"NCT03720470":[215],"COMPARE),":[217],"NCT03422822":[218],"EXTEND).":[220]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-10-09T09:14:12.587421","created_date":"2026-06-28T00:00:00"}